Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Rating of “Moderate Buy” by Analysts

Molina Healthcare, Inc. (NYSE:MOHGet Free Report) has been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $407.45.

Several equities analysts have commented on the stock. Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Wells Fargo & Company dropped their price target on shares of Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. Robert W. Baird assumed coverage on shares of Molina Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $405.00 price target on the stock. TD Cowen dropped their price target on shares of Molina Healthcare from $453.00 to $412.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. Finally, Stephens reiterated an “equal weight” rating and issued a $390.00 price target on shares of Molina Healthcare in a research note on Thursday, April 25th.

View Our Latest Stock Analysis on MOH

Molina Healthcare Stock Up 1.4 %

Shares of NYSE:MOH opened at $296.10 on Thursday. The firm’s 50 day moving average price is $323.97 and its 200 day moving average price is $361.41. The stock has a market cap of $17.35 billion, a price-to-earnings ratio of 16.07, a price-to-earnings-growth ratio of 0.91 and a beta of 0.58. Molina Healthcare has a fifty-two week low of $288.79 and a fifty-two week high of $423.92. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53.

Molina Healthcare (NYSE:MOHGet Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, beating the consensus estimate of $5.46 by $0.27. The firm had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The firm’s revenue was up 21.9% compared to the same quarter last year. During the same quarter last year, the company earned $5.81 earnings per share. As a group, equities research analysts predict that Molina Healthcare will post 23.56 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO James Woys sold 10,000 shares of the stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the sale, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at $18,504,526.95. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Molina Healthcare news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the completion of the sale, the director now owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO James Woys sold 10,000 shares of the firm’s stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the completion of the sale, the chief operating officer now directly owns 53,613 shares of the company’s stock, valued at approximately $18,504,526.95. The disclosure for this sale can be found here. Corporate insiders own 1.11% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. McIlrath & Eck LLC acquired a new position in shares of Molina Healthcare during the 4th quarter worth $34,000. VisionPoint Advisory Group LLC raised its stake in shares of Molina Healthcare by 105.6% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after buying an additional 57 shares during the last quarter. Raleigh Capital Management Inc. raised its stake in shares of Molina Healthcare by 40.4% during the 3rd quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock worth $41,000 after buying an additional 36 shares during the last quarter. Principal Securities Inc. acquired a new position in shares of Molina Healthcare during the 4th quarter worth $42,000. Finally, Householder Group Estate & Retirement Specialist LLC raised its stake in shares of Molina Healthcare by 3,933.3% during the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock worth $43,000 after buying an additional 118 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

About Molina Healthcare

(Get Free Report

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Further Reading

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.